Manufacture

The trends and challenges in oral solid dosage formulations contribute to greater stability for drugs used by patients worldwide.

A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

Understanding how choices in chromatography solutions impact overall process efficiency.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

The essential roles of optimized cell lines and vectors in accelerating bioprocessing.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

We look back on a decade of breakthroughs in advanced medicine – explore our top articles on cell and gene therapy.

A curated collection of articles examining critical questions and advancements in vaccine science and policy.

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.